Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Sundan

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Oncotarget|September 12, 2012
Oncogene addiction to c-MYC in myeloma cellsToril Holien, Anders Sundan
Cytokine & Growth Factor Reviews|May 24, 2014
The role of bone morphogenetic proteins in myeloma cell survivalToril Holien, Anders Sundan
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 23, 2018
[Research takes time]Anders Waage, Anders Sundan
Experimental Oncology|October 21, 2004
Role of osteopontin in adhesion, migration, cell survival and bone remodelingTherese Standal, Magne Borset, Anders Sundan
Cytokine & Growth Factor Reviews|October 22, 2020
Receptor binding competition: A paradigm for regulating TGF-β family actionErik Martinez-Hackert, Anders Sundan, Toril Holien
Blood Reviews|December 8, 2019
Why do myeloma patients have bone disease? A historical perspectiveMagne Børset, Anders Sundan, Anders Waage, et al.
Medical Oncology (Northwood, London, England)|February 17, 2007
Bone disease in multiple myelomaØyvind Hjertner, Therese Standal, Magne Børset, et al.
Blood|July 19, 2012
Addiction to c-MYC in multiple myelomaToril Holien, Thea Kristin Våtsveen, Hanne Hella, et al.
Biomacromolecules|September 26, 2015
The Impact of Chain Length and Flexibility in the Interaction between Sulfated Alginates and HGF and FGF-2Øystein Arlov, Finn L Aachmann, Emadoldin Feyzi, et al.
Plos One|November 22, 2017
TGF-β contamination of purified recombinant GDF15Oddrun Elise Olsen, Anette Skjærvik, Berit Fladvad Størdal, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Oncotarget|September 12, 2012
Oncogene addiction to c-MYC in myeloma cellsToril Holien, Anders Sundan
Cytokine & Growth Factor Reviews|May 24, 2014
The role of bone morphogenetic proteins in myeloma cell survivalToril Holien, Anders Sundan
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 23, 2018
[Research takes time]Anders Waage, Anders Sundan
Experimental Oncology|October 21, 2004
Role of osteopontin in adhesion, migration, cell survival and bone remodelingTherese Standal, Magne Borset, Anders Sundan
Cytokine & Growth Factor Reviews|October 22, 2020
Receptor binding competition: A paradigm for regulating TGF-β family actionErik Martinez-Hackert, Anders Sundan, Toril Holien
Blood Reviews|December 8, 2019
Why do myeloma patients have bone disease? A historical perspectiveMagne Børset, Anders Sundan, Anders Waage, et al.
Medical Oncology (Northwood, London, England)|February 17, 2007
Bone disease in multiple myelomaØyvind Hjertner, Therese Standal, Magne Børset, et al.
Blood|July 19, 2012
Addiction to c-MYC in multiple myelomaToril Holien, Thea Kristin Våtsveen, Hanne Hella, et al.
Biomacromolecules|September 26, 2015
The Impact of Chain Length and Flexibility in the Interaction between Sulfated Alginates and HGF and FGF-2Øystein Arlov, Finn L Aachmann, Emadoldin Feyzi, et al.
Plos One|November 22, 2017
TGF-β contamination of purified recombinant GDF15Oddrun Elise Olsen, Anette Skjærvik, Berit Fladvad Størdal, et al.
Pageof 8